发明名称 SOLID VALSARTAN PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a solid oral administration form comprising a pharmaceutically effective amount of valsartan or a pharmaceutically permissible salt or solvate thereof. SOLUTION: The oral solid pharmaceutical composition contains valsartan or a pharmaceutically permissible salt or hydrate thereof as an activator and a disintegrating agent, wherein the weight ratio of the activator to a disintegrator is 2.9:1 to 1:1, and 20 mg unit dosage of the activator is contained. The composition is at least 1.2 times more bioavailable than conventional valsartan capsules. COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007091758(A) 申请公布日期 2007.04.12
申请号 JP20070003546 申请日期 2007.01.11
申请人 NOVARTIS AG 发明人 GANTER SABINA MARIA;WAGNER ROBERT FRANK
分类号 A61K9/16;A61K31/41;A61K9/20;A61K9/48;A61K47/04;A61K47/12;A61K47/32;A61K47/36;A61K47/38;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P13/12;A61P25/28;A61P43/00 主分类号 A61K9/16
代理机构 代理人
主权项
地址